Coming May 2025
Get Early Access
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
5 employees
Mebias Discovery: Pioneering platform for next-gen GPCR drug discovery.
HQ
Founded
2015
Mebias Discovery is dedicated to revolutionizing drug discovery through its pioneering platform focused on G-protein coupled receptor (GPCR) targets. Utilizing a proprietary membrane protein-NMR drug discovery platform, Mebias identifies molecules that bind to GPCR targets, aiming to eliminate on-target adverse effects and enhance the therapeutic index. The company is committed to advancing and partnering its wholly owned molecules, driving innovation in the pharmaceutical industry.
Mebias Discovery has made significant strides in the field of GPCR drug discovery, leveraging its advanced technology to create novel therapeutic solutions. Its impact is underscored by the development of molecules with improved safety profiles and efficacy, addressing critical needs in medical treatments. By pushing the boundaries of traditional drug discovery methods, Mebias is poised to make substantial contributions to healthcare and pharmaceutical advancements.
Operating Status
Active
Ownership Type(s)
Venture Capital, Private
Main Product(s)
Drug Discovery
Technology
Analytics, AI
Tags
Biotech, Healthtech
Model Types
Licensing, Platform
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
Global
When was Mebias Discovery founded?
Mebias Discovery was founded in 2015.
Where is Mebias Discovery's headquarters located?
Mebias Discovery's headquarters is located in Philadelphia, PA, US.
When was Mebias Discovery's last funding round?
Mebias Discovery's most recent funding round was for $630.7k (USD) in September 2022.
How many employees does Mebias Discovery have?
Mebias Discovery has 5 employees as of Feb 5, 2024.
How much has Mebias Discovery raised to-date?
As of July 05, 2023, Mebias Discovery has raised a total of $4.1M (USD) since Sep 23, 2022.
Add Comparison
Total Raised to Date
$4.1M
USD
Last Update Sep 23, 2022
Last Deal Details
$630.7k
USD
Sep 23, 2022
Series Unknown
Current Employees
5
Last updated: Feb 5, 2024
No location information available for this company.
Locations
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts